Skip to main content

Published locations for Calcipotriene 0.005%–Betamethasone Dipropionate 0.064% Ointment Versus Topical Suspension in the Treatment of Plaque Psoriasis: A Randomized Pilot Study of Patient Preference

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Calcipotriene 0.005%–Betamethasone Dipropionate 0.064% Ointment Versus Topical Suspension in the Treatment of Plaque Psoriasis: A Randomized Pilot Study of Patient Preference

User login

  • Reset your password
  • /content/calcipotriene-0005-betamethasone-dipropionate-0064-ointment-versus-topical-suspension
  • /cutis/article/89415/psoriasis/calcipotriene-0005-betamethasone-dipropionate-0064-ointment-versus
  • /dermatology/article/89415/psoriasis/calcipotriene-0005-betamethasone-dipropionate-0064-ointment
  • /dermatology/psoriasiscollection/article/89415/psoriasis/calcipotriene-0005-betamethasone
  • /breast-cancer-icymi/article/89415/psoriasis/calcipotriene-0005-betamethasone-dipropionate-0064
  • /b-cell-lymphoma-icymi/article/89415/psoriasis/calcipotriene-0005-betamethasone-dipropionate-0064